Population Proteomics as a tool to Identify & Validate Therapeutic Targets for Brain Illnesses
Time: 11:15 am
day: Conference Day Two
Details:
- Multiplex proteomics, the measurement of hundreds to thousands of proteins, can now be applied in high throughput at very large, ‘population-scale’ sample sizes
- Outlining how population-scale proteomic screens can be used to find proteins associated with specific neurological indications
- Providing overviews of recent and upcoming consortia, including the UK Biobank Pharma Proteomics Project and the Global Neurodegeneration Proteomics Consortium
- Discussing the value of combining population proteomics with genetics (proteogenomics)
